SCHEMBL6679679

SCHEMBL6679679

NC(=O)OCCc1cscn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.38
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 2/20 0.35
KDM4C Q9H3R0 1/20 0.35
SLC6A3 Q01959 4/20 0.33
CHRM2 P08172 2/20 0.32
CHRM4 P08173 2/20 0.32
CHRM5 P08912 2/20 0.32
CHRM1 P11229 2/20 0.32
CHRM3 P20309 2/20 0.32
HTR1A P08908 1/20 0.32
TSHR P16473 1/20 0.32
CHRNB2 P17787 1/20 0.32
CYP2C19 P33261 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
DPP4 P27487 2/20 0.32
DPP8 Q6V1X1 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16252212 0.83 MAPK1 (0.38) LMNAPKMMAPK1NPSR1KDM4E
SCHEMBL2514575 0.77 PKM (0.43) LMNAPKMMAPK1NPSR1KDM4E
SCHEMBL6243139 0.76 LMNA (0.53) LMNAPKMMAPK1SLC6A3KMT2A
SCHEMBL28330925 0.76 KDM4C (0.37) LMNAPKMMAPK1NPSR1KDM4E
SCHEMBL4779862 0.75 PKM (0.42) LMNAPKMMAPK1NPSR1KDM4E
SCHEMBL28062263 0.72 NPC1 (0.34) LMNAPKMKDM4EKDM4CGAA
SCHEMBL3999262 0.72 PKM (0.45) LMNAPKMMAPK1NPSR1KDM4E
SCHEMBL860903 0.72
SCHEMBL27563452 0.71 SLC6A3 (0.34) LMNAPKMMAPK1NPSR1KDM4C
SCHEMBL27831859 0.71 TDP1 (0.37) PKMMAPK1NPSR1KDM4EKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1472226-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-03 EP disclosed
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2003045921-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-05 WO disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed